The World Health Organization (WHO) has updated its patient care guidelines to include interleukin-6 receptor blockers, a class of medicines that are lifesaving in patients who are severely or critically ill with COVID-19, especially when administered alongside corticosteroids.
These were the findings from a prospective and a living network meta-analysis initiated by WHO, the largest such analysis on the drugs to date. Data from over 10 000 patients enrolled in 27 clinical trials were considered.
- Read more about WHO recommends IL6 receptor blockers for COVID-19
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/who-recommends-il6-receptor-blockers-for-covid-19
No comments:
Post a Comment